Fat Loss & Metabolic Peptides
Provider evaluation · Appropriate testing · Ongoing monitoring
The diet that used to work suddenly stops moving the scale. The weight comes off, but the same area around the waist refuses to change. Or discipline holds all day until hunger seems to take over every night. That is usually where people start hearing names like semaglutide, tirzepatide, MOTS-c, AOD-9604 and emerging compounds such as SLU-PP-332. But those names do not describe one problem — and they do not represent one treatment. T Clinics starts by identifying what the patient is actually trying to change before deciding which metabolic conversation belongs there.
The diet that used to work suddenly stops moving the scale. The weight comes off, but the same area around the waist refuses to change. Or discipline holds all day until hunger seems to take over every night. That is usually where people start hearing names like semaglutide, tirzepatide, MOTS-c, AOD-9604 and emerging compounds such as SLU-PP-332. But those names do not describe one problem — and they do not represent one treatment. T Clinics starts by identifying what the patient is actually trying to change before deciding which metabolic conversation belongs there.
HORMONE OPTIMIZATION
PEPTIDE THERAPY
MEN'S & WOMEN'S HEALTH
IV THERAPY
HORMONE OPTIMIZATION
PEPTIDE THERAPY
MEN'S & WOMEN'S HEALTH
IV THERAPY
HORMONE OPTIMIZATION
PEPTIDE THERAPY
MEN'S & WOMEN'S HEALTH
IV THERAPY
TWO STEPS TO A FREE CONSULTATION
The signs are easy to dismiss. The cause is worth checking.
These are common experiences people bring to us. Two steps, about a minute, and a licensed provider's team takes it from there. Only a provider and lab work can determine what's behind them.
Step 1 of 2
Check off what sounds familiar
Tap every item below that applies to you. Tap it again to unselect. Check off as many as you like, or none at all.
Step 2 of 2
Choose your consultation form
Select a location below, then continue to the short consultation form.
Ready to Talk With Our Team?
Your next step is a consultation with the T Clinics USA team. We’ll use the information you provide to help coordinate the appropriate next step.
It only takes a moment to send your request.
Choose where you'll complete the short consultation form.
This is general information, not a medical assessment or diagnosis. A licensed provider determines whether any condition is present and whether treatment is appropriate. Results vary by individual.
0 items checked off
TWO STEPS TO A FREE CONSULTATION
The signs are easy to dismiss. The cause is worth checking.
These are common experiences people bring to us. Two steps, about a minute, and a licensed provider's team takes it from there. Only a provider and lab work can determine what's behind them.
Step 1 of 2
Check off what sounds familiar
Tap every item below that applies to you. Tap it again to unselect. Check off as many as you like, or none at all.
Step 2 of 2
Choose your consultation form
Select a location below, then continue to the short consultation form.
Ready to Talk With Our Team?
Your next step is a consultation with the T Clinics USA team. We’ll use the information you provide to help coordinate the appropriate next step.
It only takes a moment to send your request.
Choose where you'll complete the short consultation form.
This is general information, not a medical assessment or diagnosis. A licensed provider determines whether any condition is present and whether treatment is appropriate. Results vary by individual.
0 items checked off
When “I’m Doing Everything Right” Stops Working
Most people do not search for Fat Loss & Metabolic Peptides because they care about metabolic signaling. They search because the old rules stopped producing the old results. Maybe appetite became harder to control. Maybe weight stopped responding. Maybe the scale improved but body composition did not. Or maybe they keep hearing about GLP-1 medications, MOTS-c, AOD-9604 and newer metabolic research and want to know what actually applies to them. Those are not automatically the same problem. T Clinics looks at appetite, weight, body composition, metabolic health, medications, hormones, sleep, activity and the larger clinical picture before deciding what belongs in the plan.
When “I’m Doing Everything Right” Stops Working
Most people do not search for Fat Loss & Metabolic Peptides because they care about metabolic signaling. They search because the old rules stopped producing the old results. Maybe appetite became harder to control. Maybe weight stopped responding. Maybe the scale improved but body composition did not. Or maybe they keep hearing about GLP-1 medications, MOTS-c, AOD-9604 and newer metabolic research and want to know what actually applies to them. Those are not automatically the same problem. T Clinics looks at appetite, weight, body composition, metabolic health, medications, hormones, sleep, activity and the larger clinical picture before deciding what belongs in the plan.
THE SCALE IS ONE NUMBER
THE SCALE IS ONE NUMBER
Fat loss is the goal. The metabolic pattern determines the conversation.
Fat loss is the goal. The metabolic pattern determines the conversation.
Fat loss is the goal. The metabolic pattern determines the conversation.
Appetite, body composition, visceral fat, metabolic health and daily habits can create similar frustrations for different reasons. The clinical conversation begins by separating the target from the pattern behind it.
Appetite, body composition, visceral fat, metabolic health and daily habits can create similar frustrations for different reasons. The clinical conversation begins by separating the target from the pattern behind it.
Appetite, body composition, visceral fat, metabolic health and daily habits can create similar frustrations for different reasons. The clinical conversation begins by separating the target from the pattern behind it.
APPETITE • BODY COMPOSITION • VISCERAL FAT • METABOLIC CONTEXT
APPETITE • BODY COMPOSITION • VISCERAL FAT • METABOLIC CONTEXT
How It Works
Fat Loss Is Not One Problem
How It Works
Fat Loss Is Not One Problem
01
Start With What Stopped Responding
APPETITE • WAISTLINE • COMPOSITION
The person who once cleaned up their diet and lost ten pounds now does the same thing and barely moves the scale. Someone else loses significant weight but remains frustrated by the same area around the midsection. Another stays disciplined until evening, when hunger becomes the hardest part of the day.
They may all search for “fat loss peptides,” but they are not necessarily describing the same problem.
Appetite, total weight, visceral fat and body composition can move differently — and for different reasons.
T Clinics starts by defining the real target. What changed? What has already been tried? What does the patient actually want to improve?
01
Start With What Stopped Responding
APPETITE • WAISTLINE • COMPOSITION
The person who once cleaned up their diet and lost ten pounds now does the same thing and barely moves the scale. Someone else loses significant weight but remains frustrated by the same area around the midsection. Another stays disciplined until evening, when hunger becomes the hardest part of the day.
They may all search for “fat loss peptides,” but they are not necessarily describing the same problem.
Appetite, total weight, visceral fat and body composition can move differently — and for different reasons.
T Clinics starts by defining the real target. What changed? What has already been tried? What does the patient actually want to improve?
02
Same Goal. Very Different Treatments.
GLP-1 • MOTS-C • AOD-9604 • SLU-PP-332
Semaglutide. Tirzepatide. MOTS-c. AOD-9604. SLU-PP-332. They increasingly appear in the same metabolic conversation, but they should never be treated as interchangeable.
Semaglutide and tirzepatide belong to the established GLP-1 weight-management landscape. MOTS-c is a mitochondrial-derived peptide attracting growing interest around cellular energy and metabolic biology, but human therapeutic evidence remains limited. AOD-9604 is an investigational peptide historically studied in obesity research without established weight-loss efficacy. SLU-PP-332 is not a peptide at all — it is an experimental small molecule being studied in preclinical metabolic and exercise-mimetic research.
The names may appear beside one another online. Their evidence and clinical relevance are very different.
02
Same Goal. Very Different Treatments.
GLP-1 • MOTS-C • AOD-9604 • SLU-PP-332
Semaglutide. Tirzepatide. MOTS-c. AOD-9604. SLU-PP-332. They increasingly appear in the same metabolic conversation, but they should never be treated as interchangeable.
Semaglutide and tirzepatide belong to the established GLP-1 weight-management landscape. MOTS-c is a mitochondrial-derived peptide attracting growing interest around cellular energy and metabolic biology, but human therapeutic evidence remains limited. AOD-9604 is an investigational peptide historically studied in obesity research without established weight-loss efficacy. SLU-PP-332 is not a peptide at all — it is an experimental small molecule being studied in preclinical metabolic and exercise-mimetic research.
The names may appear beside one another online. Their evidence and clinical relevance are very different.
03
Do Not Let the Stack Become the Strategy
EVALUATION • FIT • OVERSIGHT
Online metabolic medicine can quickly become a shopping list: add the GLP-1, add the mitochondrial peptide, add the newest compound everyone is talking about.
That is not a treatment strategy.
Someone struggling primarily with appetite may need a very different conversation from someone focused on body composition, metabolic health, abdominal fat or changes in energy and performance.
T Clinics evaluates the person before building the plan. Semaglutide, tirzepatide, MOTS-c, AOD-9604, SLU-PP-332 or any other option should never become the objective simply because the name is trending.
The objective is the patient’s goal — and knowing why each part of the plan belongs there.
03
Do Not Let the Stack Become the Strategy
EVALUATION • FIT • OVERSIGHT
Online metabolic medicine can quickly become a shopping list: add the GLP-1, add the mitochondrial peptide, add the newest compound everyone is talking about.
That is not a treatment strategy.
Someone struggling primarily with appetite may need a very different conversation from someone focused on body composition, metabolic health, abdominal fat or changes in energy and performance.
T Clinics evaluates the person before building the plan. Semaglutide, tirzepatide, MOTS-c, AOD-9604, SLU-PP-332 or any other option should never become the objective simply because the name is trending.
The objective is the patient’s goal — and knowing why each part of the plan belongs there.
You have questions, we have answers.
What are Fat Loss & Metabolic Peptides?
What are Fat Loss & Metabolic Peptides?
How are semaglutide and tirzepatide different from investigational metabolic compounds?
How are semaglutide and tirzepatide different from investigational metabolic compounds?
What is MOTS-c?
What is MOTS-c?
Why is MOTS-c getting so much attention?
Why is MOTS-c getting so much attention?
What is AOD-9604?
What is AOD-9604?
What is SLU-PP-332?
What is SLU-PP-332?
Is SLU-PP-332 an exercise replacement?
Is SLU-PP-332 an exercise replacement?
Which metabolic treatment is best?
Which metabolic treatment is best?
Is tesamorelin a general weight-loss treatment?
Is tesamorelin a general weight-loss treatment?
See What Fits Your Goals